Walter Reinisch
Impact in
- Genetics top 0.01%
- Inflammatory Bowel Disease
- Gastroenterology top 0.05%
Papers in
- Genetics 404
- Inflammatory Bowel Disease 400
- Chronic Lymphocytic Leukemia Research 14
- Epidemiology 138
- Microscopic Colitis 126
- Autoimmune and Inflammatory Disorders 20
- Co-authors
- Jean Fred Colombel (111 shared papers)William J. Sandborn (115 shared papers)Paul J. Rutgeerts (48 shared papers)Brian G. Feagan (59 shared papers)Bruce E. Sands (44 shared papers)Geert D’Haens (74 shared papers)Daniel Rachmilewitz (14 shared papers)Silvio Danese (60 shared papers)
- Journals
- Gastroenterology (90 papers)Journal of Crohn s and Colitis (81 papers)Inflammatory Bowel Diseases (70 papers)The American Journal of Gastroenterology (63 papers)Alimentary Pharmacology & Therapeutics (28 papers)
- Partner nations
- AustriaUnited StatesCanada
In The Last Decade
Walter Reinisch
549 papers receiving 47.7k citations
Walter Reinisch's Hit Papers
Peers
Comparison fields: 5 of 167
- Genetics 31.7k
- Gastroenterology 2.9k
- Epidemiology 13.6k
- Immunology 6.5k
- Hematology 2.1k
Countries citing papers authored by Walter Reinisch
This map shows the geographic impact of Walter Reinisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Reinisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Reinisch more than expected).
Fields of papers citing papers by Walter Reinisch
This network shows the impact of papers produced by Walter Reinisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Reinisch. The network helps show where Walter Reinisch may publish in the future.
Co-authors
The 25 scholars most cited alongside Walter Reinisch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 571 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis Hit paper breakdown → | 2005 | 3239 |
| 2 | Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease Hit paper breakdown → | 2010 | 2593 |
| 3 | STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD Hit paper breakdown → | 2021 | 1957 |
| 4 | Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target Hit paper breakdown → | 2015 | 1517 |
| 5 | Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis Hit paper breakdown → | 2017 | 1423 |
| 6 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management Hit paper breakdown → | 2012 | 1357 |
| 7 | Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial Hit paper breakdown → | 2012 | 1314 |
| 8 | Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial Hit paper breakdown → | 2015 | 1288 |
| 9 | Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis Hit paper breakdown → | 2011 | 1070 |
| 10 | Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial Hit paper breakdown → | 2016 | 849 |
| 11 | Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis Hit paper breakdown → | 2013 | 798 |
| 12 | Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis Hit paper breakdown → | 2011 | 780 |
| 13 | Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease Hit paper breakdown → | 2014 | 778 |
| 14 | Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial Hit paper breakdown → | 2011 | 757 |
| 15 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis Hit paper breakdown → | 2012 | 726 |
| 16 | Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial Hit paper breakdown → | 2017 | 725 |
| 17 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations Hit paper breakdown → | 2009 | 719 |
| 18 | Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis Hit paper breakdown → | 2013 | 619 |
| 19 | Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry Hit paper breakdown → | 2020 | 569 |
| 20 | Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines Hit paper breakdown → | 2013 | 534 |
About Walter Reinisch
Walter Reinisch is a scholar working on Genetics, Epidemiology, Immunology, Surgery and Gastroenterology, having authored 571 papers that have together received 49.0k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (400 papers), Microscopic Colitis (126 papers), Eosinophilic Esophagitis (28 papers), Helicobacter pylori-related gastroenterology studies (25 papers), Biosimilars and Bioanalytical Methods (20 papers), Autoimmune and Inflammatory Disorders (20 papers), Immunodeficiency and Autoimmune Disorders (19 papers) and Chronic Lymphocytic Leukemia Research (14 papers). The work is most often cited by research in Genetics (31.7k citations), Gastroenterology (2.9k citations), Epidemiology (13.6k citations), Immunology (6.5k citations) and Hematology (2.1k citations). Walter Reinisch has collaborated with scholars based in Austria, United States and Canada. Frequent co-authors include Jean Fred Colombel, William J. Sandborn, Paul J. Rutgeerts, Brian G. Feagan, Bruce E. Sands, Geert D’Haens, Daniel Rachmilewitz, Silvio Danese, Gerassimos J. Mantzaris and Jewel Johanns. Their work appears in journals such as Gastroenterology, Journal of Crohn s and Colitis, Inflammatory Bowel Diseases, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.